Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinoma
Authors:
- 1 August 2015
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 48, 174-185
Abstract
No abstract availableKeywords
Funding Information
- TÜBİTAK (109S449)
This publication has 76 references indexed in Scilit:
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapyProceedings of the National Academy of Sciences, 2012
- Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled AnalysisJournal of Clinical Oncology, 2012
- Immunologic Correlates of the Abscopal Effect in a Patient with MelanomaNew England Journal of Medicine, 2012
- Therapeutic Cancer Vaccines: Current Status and Moving ForwardJNCI: Journal of the National Cancer Institute, 2012
- TNF-α/NF-κB/Snail pathway in cancer cell migration and invasionBritish Journal of Cancer, 2010
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell TransformationCell, 2009
- Systemic effects of local radiotherapyThe Lancet Oncology, 2009
- Interleukin‐10: new perspectives on an old cytokineImmunological Reviews, 2008
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007